The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Nature Reviews Cancer 17, 5 (2017).
doi:10.1038/nrc.2016.112
Authors: Adam S. Sperling, Christopher J. Gibson & Benjamin L. Ebert
Myelodysplastic syndrome (MDS) is a clonal disease that arises from the expansion of mutated haematopoietic stem cells. In a spectrum of myeloid disorders ranging from clonal haematopoiesis of indeterminate potential (CHIP) to secondary acute myeloid leukaemia (sAML), MDS is distinguished by the presence of peripheral
Source: Nature Reviews Cancer - Category: Cancer & Oncology Authors: Adam S. Sperling Christopher J. Gibson Benjamin L. Ebert Tags: Review Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer | Cancer & Oncology | Genetics | Leukemia | Myelodysplastic Syndrome | Stem Cell Therapy | Stem Cells